ReCode Therapeutics

ReCode Therapeutics Appoints New Member to Board of Director

by | Dec 2, 2022

Dallas-based life science company ReCode Therapeutics has appointed Patricia “Trisha” Millican to its board of directors, bringing with her more than 20 years of experience in the life science industry.

ReCode Therapeutics is a genetic medicines company using superior delivery to power the next wave of mRNA and gene correction therapeutics....

MORE
ReCode Therapeutics Announces Scientific Advisory Board, New Scientific Adviser
by | Nov 18, 2022
The advisers will work closely with management to support ReCode's expansion of its targeted-delivery genetics medicines platform and advance its pipeline of mRNA and gene correction therapeutics.
MORE
SMU Is Bringing Its ‘Innovative Biotech Research’ to Pegasus Park
by | Oct 24, 2022
The Biotech+ Hub at Pegasus Park in Dallas has been attracting more and more life science startups and university teams. Now a whole herd of Mustangs are about to stampede there. The SMU Institute for Computational Biosciences at Pegasus Park will have space at the 23-acre development. SMU researchers from a variety of disciplines will be focusing on bio-scientific discoveries, leveraging advanced computational algorithms and technologies.

"We're excited to give SMU faculty this new opportunity to pursue world-changing research for good and to do so in close proximity to a broad range of academic, medical, corporate, and non-profit collaborators," says SMU Provost Elizabeth Loboa. "We're excited to give SMU faculty this new opportunity to pursue world-changing research for good and to do so in close proximity to a broad range of academic, medical, corporate, and non-profit collaborators," says SMU Provost Elizabeth Loboa.
MORE
Follow the Money: Jacobs Lands Nearly $4B NASA Contract; Dallas’ ReCode Therapeutics Adds $120M to Series B Raise, and More
by | Jul 11, 2022
Plus, Enhabit Home Health Hits the NYSE, Irving Web3 Investor Raising Two New Funds, TPG leads $750M raise in clean energy firm; Coppell-based Neurolens raises $2.7M; Fort Worth's Jet Health raises $1M; Frisco edtech startup Meritize lands funding; Honeywell acquires Fort Worth nitrile glove maker Rhino Health USA; and more North Texas-related deals.
MORE

Capital Factory Opening Center for Health Innovation at Pegasus Park in Dallas

by | May 5, 2022
The Austin-based accelerator and investor plans to launch its Center for Health Innovation at Pegasus Park in Dallas by end of 2023. Its goal: connecting startups locally and across the state with each other, as well as other corporate and research players in the space.

“We're in the business of erasing boundaries in Texas—full stop,” President and Co-Founder Bryan Chambers told Dallas Innovates.
MORE
See Inside: BioLabs Coworking Lab Opens at Pegasus Park for North Texas Life Science Startups
Dallas' status as a growing biotech center got a lift with the official opening of BioLabs, a new coworking space at the Biotech+ Hub at Pegasus Park. The 37,000-square-foot facility offers shared wet labs and office space for up to 35 life science startups.

BioLabs' goal: to serve as the epicenter for life science innovation in North Texas, and to empower biotech trailblazers pursing their next breakthrough.
MORE
Dallas Biopharma ReCode Therapeutics Closes $80M Series B Round to Expand Drug Pipeline for Respiratory Diseases
by | Oct 21, 2021
The funding, which was co-led by Pfizer Ventures and EcoR1 Capital, will help drive ReCode's therapy programs for primary ciliary dyskinesia and cystic fibrosis into human clinical studies.
MORE
ReCode Therapeutics
Dallas Biopharma ReCode Therapeutics Gets $80M Series A Investment for Lung Disease Drugs
by | Mar 27, 2020
The investment from multiple sources, including local early-stage investor Hunt Technology Ventures, is the largest funding round by a startup this year in Dallas-Fort Worth.
MORE